Tecnifar
Tecnifar is a family-origin Portuguese pharmaceutical company focused on health, R&D and international partnerships.
Last updated September 29, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Tecnifar S.A. is a Portuguese pharmaceutical company headquartered in Lisbon. It presents itself as a 100% Portuguese company that has been developing "formulas for life" for more than 50 years, with an international presence. The company describes itself as a national, family-origin enterprise centred on the health sector, with innovative activities and a focus on the pharmaceutical area. Tecnifar's stated mission is to be a reference company in the Portuguese pharmaceutical sector, promoting with ethics and rigour the improvement of the quality of life of Portuguese patients. Its activities include research and development, which it says has been a serious commitment over the last 20 years, based on the belief that research contributes to the advancement of medical sciences through the research and development of new medicines. The company also pursues business development, seeking long-term commercial relationships with potential partners around the world. Its product portfolio includes both prescription and over-the-counter-style offerings. Examples visible on its website include Mindwel, a food supplement containing homotaurine that promotes cognitive function and memory; Dinaxil, a short-term symptomatic treatment for flu-like states, colds and allergic or vasomotor rhinitis, containing pseudoephedrine and triprolidine; and VE 150, a vitamin E (alphatocopherol) product used for prophylaxis, prevention and treatment of vitamin E deficiency states and reduction of the risk of myocardial infarction. Tecnifar operates from Lisbon and maintains an international presence, combining local manufacturing and commercial activity with cross-border partnerships. The company's public messaging emphasises health commitment, scientific research and long-term commercial relationships.
History
Tecnifar S.A. is a Portuguese pharmaceutical company based in Lisbon. According to its official website, it is a 100% Portuguese company that has been creating "formulas for life" for more than 50 years and has an international presence. The company describes itself as a national, family-origin enterprise centred on the health sector, with innovative activities and a focus on the pharmaceutical area. Over the last 20 years, research and development has been a serious commitment for Tecnifar. The company states that it believes in research as a way to contribute to the advancement of medical sciences through the research and development of new medicines. In parallel, it pursues business development, seeking long-term commercial relationships with potential partners around the world. Tecnifar's mission and vision are to be a reference company in the Portuguese pharmaceutical sector, promoting with ethics and rigour the improvement of the quality of life of Portuguese patients. Its product range includes food supplements such as Mindwel (containing homotaurine, for cognitive function and memory), short-term symptomatic treatments such as Dinaxil (pseudoephedrine/triprolidine for flu-like states, colds and allergic or vasomotor rhinitis), and vitamin products such as VE 150 (alphatocopherol for vitamin E deficiency and reduction of myocardial infarction risk). The company is headquartered in Lisbon, Portugal, and maintains an international presence. Its public communications emphasise health commitment, scientific research and long-term commercial relationships.
Tecnifar states it has been creating formulas for life for more than 50 years.
Research and development has been a serious commitment for Tecnifar over the last 20 years.
Products and positioning
A 100% Portuguese, family-origin pharmaceutical company committed to health, R&D and international partnerships.
Mindwel
Food supplement containing homotaurine that promotes cognitive function and memory, preventing Aβ deposition, helping preserve brain volume and reducing memory decline. 40 comp - 15.1 g.
Dinaxil
Short-term symptomatic treatment of flu-like states, colds and allergic or vasomotor rhinitis, such as nasal congestion, sneezing, rhinorrhoea. 20 comp - 60 mg / 2.5 mg pseudoephedrine / triprolidine.
VE 150
Prophylaxis. Prevention and treatment of vitamin E deficiency states. Reduction of the risk of myocardial infarction. 20 caps - 150 mg alphatocopherol.
Sources5 sources
Cite this profile: Cite the canonical profile. /brand-wiki/tecnifar-portugal · Editorial policy · How profiles are compiled